Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma.
Grossbard ML; Fidias P; Kinsella J; O'Toole J; Lambert JM; Blattler WA; Esseltine D; Braman G; Nadler LM; Anderson KC; British Journal Of Haematology, 1998, vol. 102, issue 2, p 509, ISSN 00071048. ISBN 00071048.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef